Sodium Chloride 0.9% USP 1000 mL Recall for Temperature Abuse
Fresenius Medical Care is recalling Sodium Chloride 0.9% USP 1000 mL injection (Lot #20NG02095, expiration October 2021) because the product was exposed to temperatures outside specified limits, which may affect its sterility and safety.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a pharmaceutical product. Although temperature abuse raises concerns about sterility and stability, the source text does not report any illnesses, injuries, or hospitalizations. The recall is precautionary based on a manufacturing/handling condition rather than confirmed harm.
Plain-English summary
Fresenius Medical Care Holdings, Inc. is recalling Sodium Chloride 0.9%, USP, 1000 mL (NDC 46163-0300-10), manufactured by Fresenius Medical Care North America in Waltham, MA. The affected lot is #20NG02095 with an expiration date of October 2021. This is a Class II recall.
The product was exposed to temperatures outside the manufacturer's specified storage limits. This temperature abuse may have compromised the product's integrity, including its sterility and chemical stability.
Approximately 48 cases were distributed nationwide within the United States. Sodium Chloride 0.9%, USP is used for medical purposes, and exposure to improper temperatures may render it unsuitable for its intended use.
Consumers and healthcare facilities should discontinue use of affected product from this lot and contact Fresenius Medical Care or their healthcare provider with questions.
The recalled product
- Product
- Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10
- Manufacturer
- Fresenius Medical Care Holdings, Inc.
- Category
- Drug — Injectable Solution
- Hazard
- temperature-abuse
- compromised-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 20NG02095
- Exp. Date October 2021
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27